IASLC Newsletter - May 2018
Failure to Communicate, NO MORE!
A small group of extremely motivated lung cancer patients and advocates from across the country have decided enough is enough. For fifty years it has been proclaimed that lung cancer is caused solely by a powerful addiction. The result has been the vilification of patients and a “failure to communicate” the realities of the leading cause of cancer death. The prevention-only campaign to “cure” lung cancer is fatally flawed. Research funding for lung cancer is inappropriately and inadequately low based on its overall health impact. The American people must know that #433aday die of lung cancer.
On April 26, a grassroots gathering of lung cancer activists united at the second Life and Breath Rally (@LABLifeBreath) on the lawn of the U.S. Capitol Building to communicate a critical message: everyone is at risk for lung cancer. This effort will continue as we reach out through social media to unite and mobilize everyone impacted by lung cancer. We will communicate, connect, publicize and speak out on behalf of ALL patients with lung cancer until this disease receives equitable research funding and awareness.
The Life and Breath Movement is determined to change the lung cancer conversation. We have to; our lives depend on it. And so does yours!
May 2018: The IASLC and the Journal of Thoracic Oncology (JTO) are pleased to present the Editor's Choice each month to highlight certain articles of interest. The articles below from the May 2018 issue of the JTO are free for three months. Please share with your colleagues around the globe!
Alex A. Adjei, MD, PhD
By Spigel et al.
Dr Cheryl Ho discusses the implications of this study in an accompanying editorial.
Differences in Longitudinal Health Utility Between Stereotactic Body Radiation Therapy and Surgery in Stage I Non-small Cell Lung Cancer. Running Title: Health Utility After SBRT and Surgery in Stage I NSCLC
By Wolff et al.
By McCambridge et al.
By Toyooka et al.
The intriguing issue of the differential efficacy of 5-FU analogues between Japan and Western countries is addressed in an excellent accompanying editorial by Dr. Silvia Novello and colleagues.
Invite a Fellow/Resident/Trainee for a Free Membership
The IASLC is pleased to continue to offer a free membership option for fellows, residents and trainees. Fellow memberships are available for a maximum of two years, and members are entitled to most of the regular IASLC benefits, including online access to the Journal of Thoracic Oncology. If you are a member of the IASLC and wish to invite a fellow/student/trainee to join us, please utilize the Fellow Membership invitation form or have them sign up today.
Membership Booth at ONS and ATS
The IASLC Membership Department was very pleased to welcome new members to the IASLC, as well as connect with long-standing members of the society, at two recent conferences. Thank you to all members who were attendees at either the American Thoracic Society (ATS) 2018 Conference or the 2018 Oncology Nursing Society (ONS) Congress and stopped by the booth to say hello! If you were in attendance of either meeting but still need to complete your new member registration or membership renewal, be sure to Join Today or Renew Now!
Member Account Information
It’s important for the IASLC to keep our records up to date so that members can receive important information via email and postal letter. To ensure that our records are current, please sign into your IASLC account to edit any details that may need updating. You can always email updates to firstname.lastname@example.org or call +1 720-598-1949.
Welcome New IASLC Members
Review the list of members who joined the IASLC during the month of May.
IASLC to Offer Travel Support for Advocates Attending SPORE Workshop
The IASLC will provide travel funds for seven patient advocates to attend the annual Lung Cancer SPORE (Specialized Program Of Research Excellence) workshop to be held at UT Southwestern Medical Center in Dallas, Texas, June 20-21, 2018. Patient advocates have played a major role in the design of the meeting and will continue to play a major role in regard to individual sessions and the special patient advocate session. Advocates plan to inform researchers about collaboration opportunities and projects, including online oncogene-focused patient groups (ROS1ders, ALK Positive, EGFR Resisters, Exon20 Group). Information will also be shared by advocates in blog posts and social media messaging about the importance of translational research for lung cancer. Find more information on SPORE.
Lung Cancer Awareness Month (LCAM) 2018
The LCAM website is a year-round resource to read stories of those affected by lung cancer. The lung cancer community can participate by submitting personal stories to be included in the site. You can also sign up on the site to receive email updates about its continuing development and follow the campaign on Facebook and Twitter feeds specifically devoted to the campaign.
If your organization would like to be a partner on LCAM 2018, please contact Kristin.Schultz@iaslc.org.
IASLC Foundation Cancer Care Team Award Nomination Form – NOW OPEN
We're excited to announce that the nomination period is open for the IASLC Foundation Cancer Care Team Award. Now in its second year, this award is designed to recognize outstanding patient care and aims to honor multidisciplinary teams working together to provide the highest quality cancer care.
Nominations for this award will be accepted from all over the world. The winning team will select one representative to attend the IASLC 19th World Conference on Lung Cancer (#WCLC2018) in Toronto, Canada. Learn more and nominate a team for the award.
The application period for the IASLC Patient Advocacy Travel Awards is now closed. We appreciate all of the submitted applications and will begin the review process right away. Notifications of acceptance are expected to be available by June 22, 2018.
The IASLC Patient Advocacy Travel Awards provide free registration and travel expense stipends for up to five patient advocates for the IASLC 19th World Conference on Lung Cancer (#WCLC2018) held September 23 - 26, 2018, in Toronto, Canada.
The award is open to organizations that can show 501(c)(3) or a similar type of non-profit status, and to individuals not affiliated with an advocacy organization. Find more information on the official website of the IASLC 19th World Conference on Lung Cancer.
The Lung Cancer Registry – OPEN for Patient Participation
The Lung Cancer Registry was started by the Bonnie J. Addario Lung Cancer Foundation and hopes to build a comprehensive data repository to help researchers and clinicians better identify and understand the complexities of this disease. Patients and/or caregivers on behalf of patients can participate. The IASLC is a contributing partner for this initiative. Learn more about how you can help.
Become a Member
Join the only international association solely dedicated to lung cancer research and treatment.
September 7 - 10 2019Barcelona, Spain
October 10 - 12 2019Chicago, Illinois
October 17 - 19 2019Mexico City, Mexico